| Entry |
|
|---|
| Name |
Prostaglandin E2;
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate;
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate;
Dinoprostone;
PGE2
|
|---|
| Formula |
C20H32O5
|
|---|
| Exact mass |
352.225
|
|---|
| Mol weight |
352.4651
|
|---|
| Structure |
     |
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| Arachidonic acid metabolism | | Metabolic pathways | | Neuroactive ligand-receptor interaction | | Serotonergic synapse | | Bile secretion | | Leishmaniasis | | African trypanosomiasis | | Amoebiasis | | Rheumatoid arthritis |
|
|---|
| Enzyme |
|
|---|
| Brite |
Compounds with biological roles [BR:br08001]
Lipids
Eicosanoids
Prostaglandins
C00584 Prostaglandin E2
Lipids [BR:br08002]
FA Fatty acyls
FA03 Eicosanoids
FA0301 Prostaglandins
C00584 Prostaglandin E2
 |
|---|
| Other DBs |
CAS: 363-24-6 PubChem: ChEBI: LIPIDMAPS: LipidBank: 3DMET: NIKKAJI: |
|---|
| KCF data |
ATOM 25
1 C1y C 26.1950 -14.5606
2 C1y C 26.1891 -15.9477
3 C5x C 24.8718 -14.1409
4 C1b C 27.6054 -13.1091
5 C1y C 24.8951 -16.3732
6 C2b C 27.3839 -16.8396
7 C1x C 24.0733 -15.2657
8 O5x O 24.4289 -12.7946
9 C2b C 28.7943 -13.8085
10 O1a O 24.4580 -17.7313
11 C2b C 28.5729 -16.1577
12 C2b C 30.1524 -13.8085
13 C1c C 29.7561 -16.8396
14 C1b C 31.3356 -13.1091
15 C1b C 30.9509 -16.1577
16 O1a O 29.7561 -18.2151
17 C1b C 32.5128 -13.7911
18 C1b C 32.1398 -16.8396
19 C1b C 33.7019 -13.1034
20 C1b C 33.3462 -16.1577
21 C6a C 34.8850 -13.7794
22 C1b C 34.5236 -16.8396
23 O6a O 36.1031 -13.0625
24 O6a O 34.8267 -15.1781
25 C1a C 35.7242 -16.1577
BOND 25
1 1 2 1
2 1 3 1
3 1 4 1 #Down
4 2 5 1
5 2 6 1 #Up
6 3 7 1
7 3 8 2
8 4 9 1
9 5 10 1 #Down
10 6 11 2
11 9 12 2
12 11 13 1
13 12 14 1
14 13 15 1
15 13 16 1 #Down
16 14 17 1
17 15 18 1
18 17 19 1
19 18 20 1
20 19 21 1
21 20 22 1
22 21 23 1
23 21 24 2
24 22 25 1
25 5 7 1
|
|---|
